1 / 10

Overview of Laboratory of Molecular Virology

Overview of Laboratory of Molecular Virology. Indira Hewlett, Ph.D Laboratory Chief. Director Hira L. Nakhasi, Ph.D. Deputy Director Paul A. Mied, Ph.D. Product Testing staff Robin M. Biswas, M.D. Laboratory of Bacterial, Parasitic, &Unconventional agents David Asher, M.D.

thai
Download Presentation

Overview of Laboratory of Molecular Virology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Overview of Laboratory of Molecular Virology Indira Hewlett, Ph.D Laboratory Chief

  2. Director Hira L. Nakhasi, Ph.D. Deputy Director Paul A. Mied, Ph.D. Product Testing staff Robin M. Biswas, M.D. Laboratory of Bacterial, Parasitic, &Unconventional agents David Asher, M.D. Laboratory of Molecular Virology Indira K. Hewlett, Ph.D. Laboratory of Hepatitis & Related Emerging Agents Gerardo Kaplan, Ph.D. CBER-OBRR DIVISION OF EMERGING& TRANSFUSION TRANSMITTED DISEASES

  3. LMV - History • Created during CBER reorganization of 1992 • Responsible for all HIV tests based on synthetic peptides, rDNA and molecular probes • Acquired responsibility for all HIV and HTLV products in 1999 • WNV, Vaccinia virus and software added since 2001

  4. Hewlett Lab Lee, S Wood, O Tang, S Srinivasan, K (Counter-terrorism Dayton Lab Zhang, M Khan, Q Dhawan Lab Devadas, K ORISE Rios Lab Daniel, S Grinev, A Regulatory Product Akolkar, P Geyer, S Hu, J Software Gubernot, D Sanchez, B Laboratory of Molecular Virology Indira Hewlett, Chief

  5. LMV mission- Regulatory • Review and license applications for a) in vitro tests (donor screening and diagnostic) for HIV, HTLV and other retroviruses in blood, plasma and other body fluids e.g. oral fluid b) WNV donor screening assays since 2003 c) consult reviews for Smallpox submissions d) software and instrument reviews for DETTD

  6. LMV mission- Regulatory (con’t) • Conventional Ab, Ag and NAT assays, rapid tests for diagnosis, patient monitoring, genotyping, drug resistance, and home use • Perform inspections of test kit manufacturing facilities • Develop guidelines, review criteria and standards for validation of tests • Develop policies related to their use through interagency/industry and BPAC discussions

  7. LMV mission: Research • Perform research on HIV-1, HIV-2, HTLV, WNV and Vaccinia • Conduct laboratory investigations of disease transmission and pathogenesis • Develop and evaluate new technologies and methods to ensure blood safety from transmission of HIV, WNV and Vaccinia • Develop laboratory standards/panels for standardization and lot release of HIV and WNV assays

  8. Research programs Hewlett: HIV diagnosis and pathogenesis -Genetic diversity, diagnostic significance and pathogenesis of HIV variants -Reference reagents for HIV NAT assays Srinivasan: Vaccinia virus as a model for Smallpox -Viremia in vaccinated individuals -Molecular basis for myocarditis

  9. Summary • LMV has maintained product responsibility for HIV tests for over a decade • New product responsibilities including WNV, Vaccinia, software/instruments • LMV has maintained and initiated new research programs to support its regulatory function

More Related